Neuroinflammatory disorders are conditions where immune responses damage components of the nervous system.
A common example is multiple sclerosis (MS), which is characterized by inflammatory demyelination of the central nervous system and subsequent damage to nerve cells and axons. MS research is one of the most dynamic in terms of disease mechanisms and pharmacological disease modulatory treatments.
Inflammatory mechanisms have also been implicated in the pathogenesis of many other CNS disorders including neurodegenerative and psychiatric disorders.
Group leader and research area
Lou Brundin, applied neuroscience and stem cells
Gonçalo Castelo-Branco, the role of oligodendrocytes in MS
Anna Fogdell Hahn, pathogenesis of multiple sclerosis
Robert Harris, myeloid therapy in neuroinflammation
Jan Hillert, genetics of multiple sclerosis
Maja Jagodic, epigenetics of neuroinflammation
Thomas Masterman, molecular epidemiology of multiple sclerosis
Tomas Olsson, clinical and experimental neuroimmunology
Fredrik Piehl, inflammation and neurodegeneration after neurotrauma
Marianne Schultzberg, inflammatory mechanisms in neurodegeneration
Anders Svenningsson, neurology with focus on neuroinflammatory diseases